As filed with the Securities and Exchange Commission on January 25, 2022
Registration No. 333-236377
Registration No. 333-253634
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8 REGISTRATION STATEMENT NO. 333-236377
FORM S-8 REGISTRATION STATEMENT NO. 333-253634
UNDER THE SECURITIES ACT OF 1933
CASPER SLEEP INC.
(Exact name of registrant as specified in its charter)
Delaware
|
|
46-3987647
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
Three World Trade Center
175 Greenwich Street, Floor 40
New York, New York
|
|
|
(Address of Principal Executive Offices)
|
|
(Zip code)
|
Casper Sleep Inc. 2014 Equity Incentive Plan
Casper Sleep Inc. 2015 Equity Incentive Plan
Casper Sleep Inc. 2020 Equity Incentive Plan
Casper Sleep Inc. 2020 Employee Stock Purchase Plan
(Full title of the plan)
Emilie Arel
President and Chief Executive Officer
Casper Sleep Inc.
Three World Trade Center
175 Greenwich Street, Floor 40
New York, New York 10007
(Name and address of agent for service)
(347) 941-1871
(Telephone number, including area code, of agent for service)
with copies to:
Marc D. Jaffe, Esq.
Ian D. Schuman, Esq.
Adam J. Gelardi, Esq.
Latham & Watkins LLP
1271 Avenue of the Americas
New York, New York 10020
(212) 906-1200
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated
filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
|
☐
|
Accelerated filer
|
☒
|
Non-accelerated filer
|
☐ (Do not check if smaller reporting company)
|
Smaller reporting company
|
☐
|
|
|
Emerging growth company
|
☒
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
DEREGISTRATION OF SECURITIES
This Post-Effective Amendment No. 1 relates to the following Registration Statements on Form S-8 (the “Registration Statements”)
filed by Casper Sleep Inc. (the “Company”):
• Registration Statement No. 333-236377, originally filed with the Securities and Exchange Commission (the “Commission”)
on February 11, 2020, which registered 3,132,291 of common stock of the Company (the “Shares”) for issuance under the Casper Sleep Inc. 2020 Equity Incentive Plan (the “2020 Incentive Plan”), 626,458 Shares for issuance under the Casper Sleep Inc. 2020 Employee Stock Purchase Plan (the “2020 ESPP”),
963,731 Shares for issuance under the Casper Sleep Inc. 2014 Equity Incentive Plan (the “2014 Incentive Plan”) and 4,826,993 Shares for issuance under the Casper Sleep Inc. 2015 Equity
Incentive Plan (the “2015 Incentive Plan”), in each case, as may be amended and/or restated from time to time; and
• Registration Statement No. 333-253634, originally filed with the Commission on February 26, 2021, which registered an additional 2,026,870 Shares for issuance under 2020
Incentive Plan.
On January 25, 2022, pursuant to an Agreement and Plan of Merger, dated November 14, 2021, by and among the Company, Marlin Parent Inc., a Delaware corporation (“Parent”), and Marlin Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), Merger Sub merged
with and into the Company, with the Company continuing as the surviving corporation and as a wholly-owned subsidiary of Parent (the “Merger”).
As a result of the Merger, the Company is terminating all offerings of its securities pursuant to the Registration Statements. The Company, by filing these Post-Effective Amendment
No. 1 to the Registration Statements pursuant to Rule 478 under the Securities Act of 1933, as amended, hereby terminates the effectiveness of the Registration Statements and removes from registration any and all securities registered but unsold under
the Registration Statements as of the date hereof.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in New York City, State of New York on the 25th day of
January, 2022.
|
CASPER SLEEP INC.
|
|
|
|
By:
|
/s/ Michael Monahan
|
|
|
Chief Financial Officer and Secretary
|
Note: In reliance upon Rule 478 under the U.S. Securities Act of 1933, as amended, no other person is required to sign this Post-Effective Amendment No. 1.